Literature DB >> 25062764

Widespread heterogeneous neuronal loss across the cerebral cortex in Huntington's disease.

Alissa L Nana1, Eric H Kim1, Doris C V Thu2, Dorothy E Oorschot3, Lynette J Tippett4, Virginia M Hogg4, Beth J Synek5, Richard Roxburgh6, Henry J Waldvogel1, Richard L M Faull1.   

Abstract

Huntington's disease is an autosomal dominant neurodegenerative disease characterized by neuronal degeneration in the basal ganglia and cerebral cortex, and a variable symptom profile. Although progressive striatal degeneration is known to occur and is related to symptom profile, little is known about the cellular basis of symptom heterogeneity across the entire cerebral cortex. To investigate this, we have undertaken a double blind study using unbiased stereological cell counting techniques to determine the pattern of cell loss in six representative cortical regions from the frontal, parietal, temporal, and occipital lobes in the brains of 14 Huntington's disease cases and 15 controls. The results clearly demonstrate a widespread loss of total neurons and pyramidal cells across all cortical regions studied, except for the primary visual cortex. Importantly, the results show that cell loss is remarkably variable both within and between Huntington's disease cases. The results also show that neuronal loss in the primary sensory and secondary visual cortices relate to Huntington's disease motor symptom profiles, and neuronal loss across the associational cortices in the frontal, parietal and temporal lobes is related to both Huntington's disease motor and to mood symptom profiles. This finding considerably extends a previous study (Thu et al., Brain, 2010; 133:1094-1110) which showed that neuronal loss in the primary motor cortex was related specifically to the motor symptom profiles while neuronal loss in the anterior cingulate cortex was related specifically to mood symptom profiles. The extent of cortical cell loss in the current study was generally related to the striatal neuropathological grade, but not to CAG repeat length on the HTT gene. Overall our findings show that Huntington's disease is characterized by a heterogeneous pattern of neuronal cell loss across the entire cerebrum which varies with symptom profile.

Entities:  

Keywords:  Huntington disease; cerebral cortex; clinical; neuroanatomy; pathology

Mesh:

Year:  2014        PMID: 25062764     DOI: 10.3233/JHD-140092

Source DB:  PubMed          Journal:  J Huntingtons Dis        ISSN: 1879-6397


  21 in total

Review 1.  Neuropathology and pathogenesis of extrapyramidal movement disorders: a critical update. II. Hyperkinetic disorders.

Authors:  Kurt A Jellinger
Journal:  J Neural Transm (Vienna)       Date:  2019-06-24       Impact factor: 3.575

2.  Mutant huntingtin reduction in astrocytes slows disease progression in the BACHD conditional Huntington's disease mouse model.

Authors:  Tara E Wood; Joshua Barry; Zhenquin Yang; Carlos Cepeda; Michael S Levine; Michelle Gray
Journal:  Hum Mol Genet       Date:  2019-02-01       Impact factor: 6.150

3.  Reduced dynamin-related protein 1 protects against phosphorylated Tau-induced mitochondrial dysfunction and synaptic damage in Alzheimer's disease.

Authors:  Ramesh Kandimalla; Maria Manczak; David Fry; Yeguvapalli Suneetha; Hiromi Sesaki; P Hemachandra Reddy
Journal:  Hum Mol Genet       Date:  2016-11-15       Impact factor: 6.150

4.  Pathoarchitectonics of the cerebral cortex in chorea-acanthocytosis and Huntington's disease.

Authors:  J Liu; H Heinsen; L T Grinberg; E Alho; E Amaro; C A Pasqualucci; U Rüb; K Seidel; W den Dunnen; T Arzberger; C Schmitz; M C Kiessling; B Bader; A Danek
Journal:  Neuropathol Appl Neurobiol       Date:  2018-06-10       Impact factor: 8.090

5.  Preparation, construction and high-throughput automated analysis of human brain tissue microarrays for neurodegenerative disease drug development.

Authors:  Malvindar K Singh-Bains; Nasim F Mehrabi; Adelie Y S Tan; Richard L M Faull; Mike Dragunow
Journal:  Nat Protoc       Date:  2021-03-19       Impact factor: 13.491

6.  Huntington's disease mice and human brain tissue exhibit increased G3BP1 granules and TDP43 mislocalization.

Authors:  Isabella I Sanchez; Thai B Nguyen; Whitney E England; Ryan G Lim; Anthony Q Vu; Ricardo Miramontes; Lauren M Byrne; Sebastian Markmiller; Alice L Lau; Iliana Orellana; Maurice A Curtis; Richard Lewis Maxwell Faull; Gene W Yeo; Christie D Fowler; Jack C Reidling; Edward J Wild; Robert C Spitale; Leslie M Thompson
Journal:  J Clin Invest       Date:  2021-06-15       Impact factor: 14.808

7.  Tracking Huntington's Disease Progression Using Motor, Functional, Cognitive, and Imaging Markers.

Authors:  Pubu M Abeyasinghe; Jeffrey D Long; Adeel Razi; Dorian Pustina; Jane S Paulsen; Sarah J Tabrizi; Govinda R Poudel; Nellie Georgiou-Karistianis
Journal:  Mov Disord       Date:  2021-05-20       Impact factor: 9.698

8.  Cross-sectional and longitudinal voxel-based grey matter asymmetries in Huntington's disease.

Authors:  Lora Minkova; Sarah Gregory; Rachael I Scahill; Ahmed Abdulkadir; Christoph P Kaller; Jessica Peter; Jeffrey D Long; Julie C Stout; Ralf Reilmann; Raymund A Roos; Alexandra Durr; Blair R Leavitt; Sarah J Tabrizi; Stefan Klöppel
Journal:  Neuroimage Clin       Date:  2017-10-25       Impact factor: 4.881

9.  The Spectrum of Psychiatric Pathology in a Patient with Genetically Verified Huntington's Disease.

Authors:  Samir Alkabie; Daljinder Singh; Amy Hernandez; Rhaisa Dumenigo
Journal:  Case Rep Psychiatry       Date:  2015-09-16

10.  Detection of Motor Changes in Huntington's Disease Using Dynamic Causal Modeling.

Authors:  Lora Minkova; Elisa Scheller; Jessica Peter; Ahmed Abdulkadir; Christoph P Kaller; Raymund A Roos; Alexandra Durr; Blair R Leavitt; Sarah J Tabrizi; Stefan Klöppel
Journal:  Front Hum Neurosci       Date:  2015-11-25       Impact factor: 3.169

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.